<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <atom:link href="https://www.health.harvard.edu/authors/amy-ship-md/feed/rss" rel="self" type="application/rss+xml" />
        <title><![CDATA[Harvard Health Posts by Amy Ship, MD Feed]]></title>
        <link><![CDATA[https://www.health.harvard.edu/authors/amy-ship-md]]></link>
        <image>
            <url>https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg</url>
            <height>173</height>
            <width>144</width>
            <title><![CDATA[Harvard Health Posts by Amy Ship, MD Feed]]></title>
            <link><![CDATA[https://www.health.harvard.edu/authors/amy-ship-md]]></link>
        </image>
        <description><![CDATA[Harvard Health Blog: You'll find posts from Harvard Medical School physicians and our editors on a variety of health news and issues.]]></description>
        <language>en-US</language>
        <pubDate>Mon, 21 Sep 2015 12:00:26 -0400</pubDate>

                    <item>
                <title><![CDATA[Turning to drugs and treatments before they are “ready for prime time”]]></title>
                <link>https://www.health.harvard.edu/blog/turning-to-drugs-and-treatments-before-they-are-ready-for-prime-time-201509218324</link>
                <description><![CDATA[Having a terminal illness or debilitating disease is devastating. Imagine, then, being in that situation and exhausting the available treatment options — or having limited options to begin with. It’s understandable that people in these circumstances might welcome the opportunity to try experimental drugs or treatments. But it is not always easy or expedient to gain access to such therapies. So called “right-to-try” laws are supposed to help doctors and patients access these treatments. However, it isn’t clear that right-to-try laws will actually help, and they can create additional dilemmas in what are already complicated situations.]]></description>
                <author><![CDATA[Amy Ship, MD]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/turning-to-drugs-and-treatments-before-they-are-ready-for-prime-time-201509218324</guid>
                <pubDate>Mon, 21 Sep 2015 12:00:26 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/amy-ship-md/feed/rss"><![CDATA[Harvard Health Posts by Amy Ship, MD Feed]]></source>
                            </item>
            </channel>
</rss>
